This content is protected against AI scraping.
The White House’s new 2026 National Drug Control Strategy outlines a broader federal crackdown on intoxicating hemp products like delta-8 THC, THC-O, THCP, and other synthetic cannabinoids that became widely available after the 2018 Farm Bill. The administration says many of these products are being sold outside regulated systems, and it cites new “legal authority” gained through recent federal legislation to take stronger action against certain hemp-derived cannabinoids, with changes expected to take effect in November 2026.
The strategy focuses heavily on concerns around youth access, high-potency cannabis products, accidental ingestion of edibles, and mental health risks, while calling for expanded enforcement and tighter regulation of unregulated or synthetic cannabinoid products. Critics in the cannabis industry argue the report relies heavily on alarm-driven framing and does not reflect data showing licensed cannabis markets maintain strong age-verification compliance and have not been shown to increase youth use rates.
At the same time, the administration appears to support regulated CBD access. Trump has called for preserving access to full-spectrum CBD products, and a new federal pilot program allows limited Medicare and Medicaid coverage for certain low-THC CBD products.
This is a summary.
Read the original article: Trump Administration Claims ‘New Legal Authority’ to Dismantle Intoxicating Hemp Products
Original article written by Tony Lange. Published on May 5, 2026 by Cannabis Business Times.
